The Indian Council of Medical Research and the National Task Force on Covid-19 have dropped the use of Ivermectin and Hydroxychloroquine drugs from their revised guidelines for the treatment of the infection. “HCQ may be considered for removal from guideline, with recommendation to use with caution only in clinical trial setting,” said the document titled ‘considerations for exclusion of Ivermectin …
New Delhi: Convalescent plasma therapy did not show benefit in reducing mortality risk among COVID-19 patients, according to an interim analysis of a randomised controlled trial done at AIIMS here to assess the efficacy of this mode of treatment. AIIMS Director Dr Randeep Guleria told PTI on Thursday no clear mortality benefit of convalescent plasma therapy was seen during a …
